Naloxone Training for Opioid Overdose
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to reduce opioid overdose deaths by training citizens to use naloxone, a life-saving drug that reverses overdoses. Participants will use an app to receive alerts about nearby overdoses and learn to respond effectively. The study includes two groups: one receiving online naloxone training and another receiving general opioid information without naloxone specifics until the study concludes. It suits individuals living in PulsePoint communities who speak English and can use a smartphone app. As an unphased trial, this study allows participants to contribute to community health by learning vital skills to save lives.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this training is safe for participants?
Research has shown that naloxone training is safe and easy for participants to manage. One study found that when individuals learned to use naloxone and assisted someone during an overdose, they successfully revived the person 90% of the time. This indicates that the training is effective and participants handle it well.
Another study demonstrated that training improved individuals' ability to recognize and respond to overdoses over time. No evidence suggests harm from learning how to use naloxone, as the training resembles other educational programs.
Overall, these findings suggest that naloxone training, such as that included in the ORRS project, is safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to tackle opioid overdoses through innovative training methods. The Opioid Rapid Response System (ORRS) training offers a unique approach by delivering online Naloxone training, which could make life-saving education more accessible and convenient. Unlike standard treatments that focus solely on the medication itself, this trial emphasizes empowering people with the knowledge to act quickly in emergencies, potentially increasing the effectiveness of overdose response efforts. By comparing ORRS training with non-active training, researchers hope to find out how critical comprehensive education is in managing opioid overdoses.
What evidence suggests that the Opioid Rapid Response System (ORRS) training is effective for opioid overdose response?
Research has shown that teaching people to use naloxone can greatly reduce deaths from opioid overdoses. One study found that 90% of overdose victims were successfully revived by individuals who had received community naloxone training. This indicates that naloxone training can significantly increase the chances of saving lives during an overdose. In this trial, participants in the Opioid Rapid Response System (ORRS) training group will receive online naloxone training, aiming to expand these benefits by connecting trained individuals to overdose situations through technology. This approach could help people get assistance faster, especially in areas where emergency services are slow. Meanwhile, the waitlist group will initially receive non-active opioid overdose response training, focusing on opioid prevalence and addiction without naloxone management. Overall, past evidence supports the idea that naloxone training is a powerful tool in fighting opioid overdoses.12467
Who Is on the Research Team?
Hye Jeong Choi
Principal Investigator
Univeristy of Missouri
Michael Hecht
Principal Investigator
Real Prevention
Are You a Good Fit for This Trial?
This trial is for adults over 18 who live in communities using the PulsePoint app, speak English fluently, and can download and use apps on a smartphone. It's not suitable for those who don't meet these criteria.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Development
Refine and complete the development of the Opioid Rapid Response System (ORRS)
Training
Participants receive online Naloxone training or non-active opioid overdose response training
Follow-up
Participants are monitored for their intent to intervene, self-efficacy, response efficacy, knowledge, and concerns related to opioid overdose management
What Are the Treatments Tested in This Trial?
Interventions
- Non-active opioid overdose response training
- Opioid Rapid Response System (ORRS) training
Non-active opioid overdose response training is already approved in United States, European Union, Canada for the following indications:
- Reversal of opioid overdose
- Reversal of opioid overdose
- Reversal of opioid overdose
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Missouri-Columbia
Lead Sponsor